Yoshikuni Nagashio Selected Research

Yoshikuni Nagashio Research Topics

Disease

8	Pancreatitis 03/2024 - 02/2002
5	Pancreatic Neoplasms (Pancreatic Cancer) 02/2024 - 01/2009
4	Fistula 12/2023 - 01/2021
4	Neoplasms (Cancer) 12/2023 - 10/2018
4	Fibrosis (Cirrhosis) 04/2010 - 07/2004
3	Pathologic Constriction (Stenosis) 03/2024 - 09/2020
3	Body Weight (Weight, Body) 04/2010 - 12/2004
3	Chronic Pancreatitis 01/2009 - 11/2005
2	Atrophy 11/2005 - 12/2004
1	Acquired Immunodeficiency Syndrome (AIDS) 12/2024
1	Jaundice (Icterus) 05/2024
1	Liver Diseases (Liver Disease) 05/2024
1	Sclerosing Cholangitis 05/2024
1	Gastric Outlet Obstruction 03/2024
1	Obstructive Jaundice (Cholestatic Jaundice) 02/2024
1	Adenoma (Adenomas) 12/2023
1	Peritonitis 09/2023
1	Neoplasm Metastasis (Metastasis) 01/2023
1	Encephalitis (Encephalitis, Rasmussen) 09/2022
1	Fever (Fevers) 09/2022
1	Hepatocellular Carcinoma (Hepatoma) 09/2022
1	Xanthogranulomatous cholecystitis 08/2021
1	Gallbladder Neoplasms (Gallbladder Cancer) 08/2021
1	Acinar Cell Carcinoma 01/2021
1	Afferent Loop Syndrome 01/2019
1	Nausea 10/2018
1	Primitive Neuroectodermal Tumors (PNET) 10/2018
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 10/2018
1	Cysts 11/2014
1	Wounds and Injuries (Trauma) 04/2010
1	Pancreatic Diseases (Pancreatic Disease) 01/2009
1	Autoimmune Pancreatitis 01/2009
1	Autoimmune Hepatitis 01/2009
1	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 01/2009
1	Acute Necrotizing Pancreatitis 11/2007
1	Acute Hemorrhagic Pancreatitis 11/2007
1	Hyperbilirubinemia 02/2002

Drug/Important Bio-Agent (IBA)

4	CeruletideIBA 04/2010 - 07/2004
3	EnzymesIBA 05/2024 - 02/2002
3	Hydroxyproline (4 Hydroxyproline)IBA 04/2010 - 07/2004
2	PlatinumIBA 12/2023 - 01/2021
2	MetalsIBA 01/2023 - 01/2019
2	Transforming Growth Factor beta1 (TGF beta 1)IBA 04/2010 - 11/2007
2	Messenger RNA (mRNA)IBA 04/2010 - 11/2007
2	Taurocholic Acid (Sodium Taurocholate)IBA 11/2007 - 11/2005
1	Immune Checkpoint InhibitorsIBA 05/2024
1	Immunosuppressive Agents (Immunosuppressants)IBA 05/2024
1	PlasticsIBA 12/2023
1	atezolizumabIBA 09/2022
1	Bevacizumab (Avastin)FDA Link 09/2022
1	Diazepam (Valium)FDA LinkGeneric 09/2022
1	SteroidsIBA 09/2022
1	folfirinoxIBA 08/2022
1	Biomarkers (Surrogate Marker)IBA 08/2021
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2021
1	BismuthIBA 09/2020
1	Fluorouracil (Carac)FDA LinkGeneric 10/2018
1	Streptozocin (Streptozotocin)FDA Link 10/2018
1	Tumor Biomarkers (Tumor Markers)IBA 11/2014
1	Amylases FDA Link 11/2014
1	Gemcitabine FDA Link 08/2010
1	TrypsinIBA 04/2010
1	Immunoglobulin M (IgM)IBA 01/2009
1	Immunoglobulin G (IgG)IBA 01/2009
1	Immunoglobulin A (IgA)IBA 01/2009
1	GlucocorticoidsIBA 01/2009
1	Fibronectins (Fibronectin)IBA 11/2007
1	Transforming Growth Factors (Transforming Growth Factor)IBA 11/2007
1	Protease Inhibitors (Protease Inhibitor)IBA 07/2007
1	Arginine (L-Arginine)FDA Link 11/2005
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 11/2005
1	Collagen Type IV (Type IV Collagen)IBA 11/2005
1	Proteins (Proteins, Gene)FDA Link 11/2005
1	Transforming Growth Factor beta (TGF-beta)IBA 12/2004
1	Transforming Growth Factor beta Receptors (TGF beta Receptors)IBA 12/2004
1	Type 1 Angiotensin ReceptorIBA 07/2004
1	Angiotensin IIIBA 07/2004

Therapy/Procedure

8	Stents 03/2024 - 01/2019
6	Drug Therapy (Chemotherapy) 02/2024 - 08/2010
4	Intraperitoneal Injections 04/2010 - 07/2004
3	Self Expandable Metallic Stents 02/2024 - 09/2023
2	Choledochostomy 09/2023 - 01/2021
2	Punctures 03/2023 - 01/2023
2	Therapeutics 09/2022 - 10/2018
1	Pancreaticoduodenectomy 12/2024
1	Radiofrequency Ablation 12/2023
1	Genomic Medicine 03/2023
1	Lasers (Laser) 01/2023
1	Gastroenterostomy 01/2019
1	Chemoradiotherapy 08/2010